Term Name: molibresib
Synonyms: 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide, GSK 525762A, GSK-525762A, GSK525762, GSK525762A, I-BET 762, I-BET-762, I-BET762, molibresib, molibresibum
Definition: A member of the class of triazolobenzodiazepine that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine substituted by methyl, 2-(ethylamino)-2-oxoethyl, 4-chlorophenyl, and methoxy groups at positions 1, 4S, 6, and 8, respectively. It is an orally bioavailable inhibitor of BET family of proteins that has demonstrated antitumour activity in preclinical models of solid and hematologic malignancies.
Ontology: ChEBI [CHEBI:95082]  ( EBI )

Relationships
is a type of: aromatic ether monochlorobenzenes secondary carboxamide triazolobenzodiazepine
has_role: antineoplastic agent apoptosis inducer bromodomain-containing protein 4 inhibitor